These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23486696)

  • 1. The Canadian recommendations on screening for type 2 diabetes.
    Wald NJ; Haddow JE
    J Med Screen; 2012 Dec; 19(4):163. PubMed ID: 23486696
    [No Abstract]   [Full Text] [Related]  

  • 2. Obituary: the Canadian Task Force on Preventive Health Care.
    CMAJ; 2003 Nov; 169(11):1137, 1139. PubMed ID: 14638633
    [No Abstract]   [Full Text] [Related]  

  • 3. Estimating benefits and harms of screening across subgroups: the Canadian Task Force on Preventive Health Care integrates the GRADE approach and overcomes minor challenges.
    Pottie K; Connor Gorber S; Singh H; Joffres M; Lindsay P; Brauer P; Jaramillo A; Tonelli M
    J Clin Epidemiol; 2012 Dec; 65(12):1245-8. PubMed ID: 22995856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening of type 2 diabetes, the French guidelines].
    Simon D; Cogneau J; Sauvanet JP
    Soins; 2004 Apr; (684 Pt 2):29-32. PubMed ID: 15151090
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis & commentary: The US Preventive Services Task Force should consider a broader evidence base in updating its diabetes screening guidelines.
    Villarivera C; Wolcott J; Jain A; Zhang Y; Goodman C
    Health Aff (Millwood); 2012 Jan; 31(1):35-42. PubMed ID: 22232092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for type 2 diabetes mellitus to prevent vascular complications: updated recommendations from the Canadian Task Force on Preventive Health Care.
    Feig DS; Palda VA; Lipscombe L;
    CMAJ; 2005 Jan; 172(2):177-80. PubMed ID: 15655234
    [No Abstract]   [Full Text] [Related]  

  • 7. The public's response to the U.S. Preventive Services Task Force's 2009 recommendations on mammography screening.
    Squiers LB; Holden DJ; Dolina SE; Kim AE; Bann CM; Renaud JM
    Am J Prev Med; 2011 May; 40(5):497-504. PubMed ID: 21496748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer screening: from science to recommendation.
    Petitti DB; Calonge N; LeFevre ML; Melnyk BM; Wilt TJ; Schwartz JS;
    Radiology; 2010 Jul; 256(1):8-14. PubMed ID: 20574080
    [No Abstract]   [Full Text] [Related]  

  • 9. Omissions of the U.S. Preventive Services Task Force.
    Zuurbier RA
    Radiology; 2011 Apr; 259(1):305; author reply 305-6. PubMed ID: 21436102
    [No Abstract]   [Full Text] [Related]  

  • 10. The 2009 U.S. Preventive Services Task Force guidelines ignore important scientific evidence and should be revised or withdrawn.
    Kopans DB
    Radiology; 2010 Jul; 256(1):15-20. PubMed ID: 20574081
    [No Abstract]   [Full Text] [Related]  

  • 11. Recommendations from the Canadian Diabetes Association. 2003 guidelines for prevention and management of diabetes and related cardiovascular risk factors.
    Harris SB; Lank CN
    Can Fam Physician; 2004 Mar; 50():425-33. PubMed ID: 15318682
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for high blood pressure: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am Fam Physician; 2003 Nov; 68(10):2019-22. PubMed ID: 14655813
    [No Abstract]   [Full Text] [Related]  

  • 13. Reframing the US Preventive Services Task Force recommendations on screening for glaucoma.
    Parrish RK
    Am J Ophthalmol; 2014 Nov; 158(5):860-2. PubMed ID: 25437830
    [No Abstract]   [Full Text] [Related]  

  • 14. Type 2 diabetes in the First Nations population: a case example of clinical practice guidelines.
    Shubair MM; Tobin PK
    Rural Remote Health; 2010; 10(4):1505. PubMed ID: 20958092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enough guidelines already.
    Roedde S
    Can Fam Physician; 1999 Mar; 45():573-5. PubMed ID: 10099793
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention and screening recommendations in type 2 diabetes: Review and critical appraisal of clinical practice guidelines.
    Diab M; Barhoosh HA; Daoudi B; AlMukdad SI; Zaghloul NH; Ashour M; Abdelrahman IA; Paravattil B; Wilby KJ
    Prim Care Diabetes; 2019 Jun; 13(3):197-203. PubMed ID: 30553698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for diabetes in general practice.
    Harris GD; White RD
    Prev Cardiol; 2004; 7(3):142; author reply 143-4. PubMed ID: 15334738
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of family history in clinical guidelines for diabetes and colorectal cancer.
    Peterson BA; Gwinn ML; Valdez RA
    Am J Prev Med; 2012 Jan; 42(1):65-70. PubMed ID: 22176849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes: causes, complications, and new screening recommendations. I.
    Butler RN; Rubenstein AH; Gracia AM; Zweig SC
    Geriatrics; 1998 Mar; 53(3):47-50, 53-4. PubMed ID: 9511774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Colorectal carcinoma screening in patients with type 2 diabetes mellitus].
    Nagel JM; Göke B
    Z Gastroenterol; 2006 Nov; 44(11):1153-65. PubMed ID: 17115358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.